Our results in this study are in favor of a strong correlation between c-kit and ACC, and hence point to the prospect of using c-kit as a novel biomarker for prognosis and diagnosis of ACC, as well as a potential molecular therapeutic target for ACC. Here, KIT is linked to adrenal cortex carcinoma.